However, as noted by Mahiques-Santos, while melanotan II has been investigated as a potential ED treatment, it has been largely superseded by a nasally administered molecule (PT-141, Palatin Technologies), an active metabolite of the molecule [1]
The simplest way to think about it is this: GLP-1 injections are pharmaceutical hormone mimics Reducore is a nutritional/metabolic support formula designed to naturally support several related pathways They are not equivalent in potency, but there is some overlap in their goals
While the GLP-1s affected familiar territory, they also triggered activity in the central amygdala, a region associated with desire that is deeper in the brain than scientists previously thought GLP-1s could directly reach
The active ingredient (semaglutide) is FDA-approved, and compounding follows strict regulatory pathways
In addition, counterfeit drugs as well as compounded drugs, which may not contain the same active ingredient as FDA-approved drugs, have reached the public